Clinical Trial Update: A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. [Phase 3]

View source ↗

Summary

Phase 3 trial update for belumosudil in combination with corticosteroids in newly diagnosed chronic graft-versus-host disease; the study is active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Belumosudil (belumosudil)

Snippet

Sponsor: Sanofi | Conditions: Chronic Graft Versus Host Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING